Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elisabetta Verdun di Cantogno

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

BMC Neurology

Medicine

Neurology

2010

English

Is Multiple Sclerosis a Length-Dependent Central Axonopathy? The Case for Therapeutic Lag and the Asynchronous Progressive MS Hypotheses

Multiple Sclerosis and Related Disorders

Medicine

Neurology

2017

English

Related publications

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis

Neurology

2011

English

Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil

English

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

English

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

English

Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

English

Adherence to Self-Administering Interferon-Β1a Using RebiSmart® Device in Mexican Patients With Relapsing Multiple Sclerosis

PLoS ONE

Multidisciplinary

2020

English

Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 MCG for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

English

Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study

Journal of the Neurological Sciences

Neurology

2016

English

Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings From the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elisabetta Verdun di Cantogno

Patient-Rated Suitability of a Novel Electronic Device for Self-Injection of Subcutaneous Interferon Beta-1a in Relapsing Multiple Sclerosis: An International, Single-Arm, Multicentre, Phase IIIb Study

Is Multiple Sclerosis a Length-Dependent Central Axonopathy? The Case for Therapeutic Lag and the Asynchronous Progressive MS Hypotheses

Related publications

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Subjective Patient-Reported Versus Objective Adherence to Subcutaneous Interferon Β-1a in Multiple Sclerosis Using RebiSmart®: The CORE Study

Adherence to Self-Administering Interferon-Β1a Using RebiSmart® Device in Mexican Patients With Relapsing Multiple Sclerosis

Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 MCG for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

Subcutaneous Interferon Β-1a in Pediatric Patients With Multiple Sclerosis: Regional Differences in Clinical Features, Disease Management, and Treatment Outcomes in an International Retrospective Study

Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings From the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis